Edgewise Therapeutics
Emily Bonnabeau is the Manager of Clinical Operations at Edgewise Therapeutics since September 2022. Prior to this role, Emily held positions at Syneos Health as a Senior Clinical Research Associate and Central Monitoring Lead. In these roles, Emily oversaw global central monitoring teams, conducted remote site management, and ensured regulatory compliance. Emily also has experience as a Clinical Research Coordinator at Duke University School of Nursing, where Emily managed federally funded projects, conducted qualitative data analysis, and coordinated nationwide learning collaboratives. With a background in sociology, black studies, criminology, and political science, Emily has a strong foundation in research and project management.
This person is not in any offices
Edgewise Therapeutics
1 followers
Edgewise Therapeutics is a biotechnology company harnessing proven expertise and understanding of skeletal muscle physiology to develop novel, transformative therapies for serious muscle diseases. Based in Boulder, Colorado, we have built a state-of-the-art muscle research facility to capitalize on new insights into the nature and consequences of muscle adaptation and injury with disease. Edgewise recently closed it’s Series B financing round which will support the advancement of Edgewise Therapeutic’s lead product candidate into clinical development for Duchenne and Becker Muscular Dystrophy (DMD and BMD) as well as expansion of the company’s pipeline. The company’s leadership team has founded multiple biotechnology startups, several of which have gone on to become publicly-traded companies and brings to bear a depth of experience in drug discovery, development and commercialization.